| Product NDC: | 55566-8401 |
| Proprietary Name: | FIRMAGON |
| Non Proprietary Name: | degarelix |
| Active Ingredient(s): | 40 mg/mL & nbsp; degarelix |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | POWDER, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55566-8401 |
| Labeler Name: | Ferring Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022201 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090302 |
| Package NDC: | 55566-8401-1 |
| Package Description: | 2 VIAL, GLASS in 1 CARTON (55566-8401-1) > 3 mL in 1 VIAL, GLASS (55566-8401-0) |
| NDC Code | 55566-8401-1 |
| Proprietary Name | FIRMAGON |
| Package Description | 2 VIAL, GLASS in 1 CARTON (55566-8401-1) > 3 mL in 1 VIAL, GLASS (55566-8401-0) |
| Product NDC | 55566-8401 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | degarelix |
| Dosage Form Name | POWDER, METERED |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090302 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Substance Name | DEGARELIX ACETATE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |